IBD Essentials

The Stenova trial: A new treatment option with Ontunisertib in fibrostenosing CD

25:22

Florian Rieder from Cleveland Clinic, Cleveland, USA, internationally renowned IBD, intestinal fibrosis expert and principal investigator of the new treatment option with the oral GI-restricted small molecule inhibitor of ALK-5 Ontunisertib in fibrostenosisng CD